Understanding causes of the rising incidence of thyroid cancer – What can mutations in the BRAF oncogene tell us about causes and diagnostic pathways for thyroid cancer? [ 2013 - 2017 ]

Research Grant

Researchers: Dr Susan Jordan (Principal investigator) ,  A/Pr Philippa Youl ,  Dr Chris Bain ,  Dr Nirmala Pandeya ,  Prof Peter Baade

Brief description The occurrence of thyroid cancer has increased rapidly over the last 25 years but the cause is unknown. The increase may reflect ‘over-diagnosis’ of less harmful cancers or greater exposure to causes of this cancer. Evidence suggests that a gene mutation (BRAF) in thyroid cancers is important in understanding the drivers of the increase. This study will examine the increase in thyroid cancer by investigating causes and diagnostic pathways considering the presence or absence of BRAF mutations.

Funding Amount $AUD 610,222.10

Funding Scheme Project Grants

Notes Standard Project Grant